UNLABELLED There have been significant advances in the past several years with regard to targeted therapy and immunotherapy for cancer. This is highlighted in melanoma, where treatment with targeted therapy (against the BRAF oncoprotein) results in responses in the majority of patients, although the duration of response is limited. In contrast, treatment with immunotherapy results in a lower re...

The 2015 St. Gallen Consensus Conference on early breast cancer took place in Vienna, Austria, for the first time. After 3 days of high-level presentations by international panel members of clinical trials having been reported recently in the field, the traditional Saturday voting tried to translate the assembled knowledge into clinical treatment recommendations intended to guide clinical pract...

The aim of the review is to highlight principle action, effectiveness and prospects for development targeted therapy in treatment patients with malignant neoplasms based on recent clinical studies. Thanks active study tumor biology, specific target molecules have been discovered it has become possible cells drugs. Today, drugs are used tumors various organs continue demonstrate their effectiven...